Dr. Marius C. Florescu, MD

Dr. Florescu practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Florescu's NPI, 1003869660, was assigned on May 17, 2006. Dr. Florescu holds Nebraska license 23656.

Dr. Florescu's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Florescu also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Florescu's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Florescu is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Florescu to 1 more hospital, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Florescu practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Florescu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Florescu is licensed in Nebraska.

CMS data shows 578 Medicare services from Dr. Florescu across 10 procedure codes in 2024, for 279 Medicare patients. Medicare paid $51,794 for them.

CMS counts 279 Medicare patients who saw Dr. Florescu in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 4.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Florescu's median patient age at 72, with 49% women.

In 2024, Dr. Florescu wrote 418 Medicare Part D claims for 79 patients. 76% of them were for generic drugs. CMS names the drug for 282 of them, across 11 drugs with 11 or more claims each, at $84,968 in total drug cost. In 2023, CMS named 333 claims across 14 drugs.

Dr. Florescu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Florescu as offering telehealth.

Dmand AI links 23 papers to Dr. Florescu, published from 2011 to 2024. 2012 was the busiest year, with 5. The most frequent topics are Renal Dialysis, Arteriovenous Shunt, Surgical and Catheterization, Central Venous. Dr. Florescu has published most often in Semin Dial. Dr. Florescu's most frequent co-authors are Troy J. Plumb, MD, Nathan Christopher Birch, MD and Wendy J. Grant, MD.

CMS Open Payments shows 14 general payments to Dr. Florescu from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 60% of the total. Penumbra, Inc. paid the most, $2,270.